Ginkgo Bioworks price target lowered to $6 from $7 at BTIG
BTIG analyst Mark Massaro lowered the firm’s price target on Ginkgo Bioworks (DNA) to $6 from $7 and keeps a Sell rating on the shares ...
Struggling Ginkgo Bioworks says it will step away from soon-to-open Seaport building
One of the few bright spots in Boston’s life-science lab space market this year has dimmed.
Hosted on MSN1mon
Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why
DNA Price Action: Ginkgo Bioworks shares were up 16.7% at $7.26 at the time of publication, according to Benzinga Pro.
Morningstar1d
Ginkgo Bioworks Holdings Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Investing1d
Ginkgo Bioworks Holdings (DNA)
In a recent transaction, Steven P. Coen, the Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), sold shares of the company's stock, reportedly to cover tax ...
Ginkgo Bioworks: Not Enough Progress
Ginkgo Bioworks reported mixed Q3, with a $45M one-time revenue boost masking underlying revenue growth issues. Read why I ...
Ginkgo cancels move to new South Boston lab, exits Cambridge office
Ginkgo Bioworks is headquartered at 27 Drydock Avenue in Boston's Seaport. Ginkgo has canceled its planned move into a ...
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q3 Loss, Tops Revenue Estimates
Ginkgo Bioworks (DNA) delivered earnings and revenue surprises of 55% and 102.77%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Insights into Ginkgo Bioworks Holdings's Upcoming Earnings
Return on Assets (ROA): Ginkgo Bioworks Holdings's ROA lags behind industry averages, suggesting challenges in maximizing ...